Resbiotic Expands Global Reach with Strategic Partnership in Mexico

Resbiotic and Grupo Columbia collaborate to expand access to clinically validated probiotics in Mexico.

0
12

New Distribution Agreement with Grupo Columbia Strengthens International Presence

Resbiotic Nutrition Inc has entered into a strategic distribution agreement with Grupo Columbia S.A. de C.V., a key player in Mexico’s probiotic and pharmaceutical sectors. Under this collaboration, resB® Lung Support Probiotic will be the first product commercialised across Mexico through Laboratorios Columbia, expanding resbiotic’s footprint in Latin America.

resB®, developed by Dr. C. Vivek Lal, was designed to enhance respiratory function, support gut health, and promote better sleep. Dr. Lal, an expert in pulmonary microbiome research, serves as Director of Clinical Innovation and Director of Pulmonary Microbiome & Innovation Labs at the University of Alabama at Birmingham. He is also the founder of Resbiotic Nutrition, Alveolus Bio Inc., and Able Biolabs, with operations in Birmingham, AL, and Boston, MA.

A Milestone in Resbiotic’s Global Expansion

This agreement marks a major step in resbiotic’s global growth strategy, reinforcing its commitment to delivering science-backed, targeted probiotic solutions to consumers worldwide. By leveraging Laboratorios Columbia’s established salesforce and medical marketing capabilities, resbiotic aims to introduce its formulations to a wider healthcare and consumer audience in Mexico.

“Following our strong brand growth in North America, expanding into Mexico through strategic partnerships is a key milestone in our global distribution strategy,” said Dr. C. Vivek Lal, Founder of resbiotic“Laboratorios Columbia’s leadership in probiotic-based health solutions makes them an ideal partner to bring our clinically researched formulations to consumers seeking effective microbiome support for chronic conditions.”

Addressing Global Health Challenges with Targeted Microbiome Solutions

Resbiotic’s product line is built around the Gut-X Axis, a concept that highlights the interconnected relationship between the gut and other physiological systems. By modulating targeted biological pathways, resbiotic’s formulations are designed to support overall health and address specific chronic conditions.

Key Products in the Resbiotic Portfolio

  • resB® Lung Support Probiotic – The world’s first respiratory probiotic, designed to support lung health in response to pollution, smoking, allergies, and chronic lung conditions.
  • resG® Prebeet Prebiotic – A prebiotic blend formulated to promote gut health and metabolic balance.
  • resM® GLP-1 Postbiotic – A postbiotic formulation supporting metabolic and gut health through innovative GLP-1 modulation.
resB® Lung Support Probiotic, formulated with clinically validated strains (RSB11, RSB12, RSB13), is designed to support lung health in individuals exposed to pollution, smoking, and allergens.

A Strong Partnership for the Future

The partnership with Laboratorios Columbia ensures that resbiotic’s formulations will reach health-conscious consumers, healthcare practitioners, and retailers across Mexico. With a growing demand for clinically validated probiotic and biotic-based solutions, this collaboration positions both companies for long-term success in the region.

“We are excited to work with Dr. Lal and resbiotic to bring resB® Lung Support and future innovations to the Mexican market,” said Carlos Quintanilla, Vice President of New Business Development at Laboratorios Columbia“Consumers are increasingly seeking high-quality, science-backed supplements, and resbiotic’s formulations align perfectly with our mission to offer innovative, evidence-based health solutions.”

By combining scientific expertise with strategic global expansion, resbiotic continues to push the boundaries of microbiome science, ensuring that physician-formulated, research-driven supplements are accessible to a broader international audience.

About Resbiotic Nutrition

Resbiotic Nutrition is a science-driven health and wellness company focused on probiotic, prebiotic, and postbiotic formulations designed to enhance gut, lung, and overall microbiome health. Its physician-formulated products are developed based on rigorous clinical research to address specific health needs through microbiome modulation.

About Laboratorios Columbia

Laboratorios Columbia is a leading pharmaceutical and probiotic manufacturer in Mexico, known for its innovative health solutions and strong presence in the medical and consumer health sectors. With a robust salesforce and medical marketing infrastructure, the company is dedicated to expanding access to clinically validated supplements across the region.

LEAVE A REPLY

Please enter your comment!
Please enter your name here